The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-8.1% to $168.50
Predicted High$183.00in 2 weeks
Predicted Low$168.50at 6 months
Max Drawdown (predicted)-8.1%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 17, 2026 12:55 am
Bear
BDX trends lower to
$168.50
(-8.1% from $183.40)
by Feb 2027.
decay
ThesisBDX trades well above composite fair value near $97 but has defensive characteristics, low beta, and calm risk-on tape that limit downside speed. Expect a slow drift lower toward the deterministic $168 endpoint as value gravity gradually reasserts, with modest chop rather than a sharp break.
Invalidated ifA close above $195 or clear break below $165 within 2 months would falsify the slow-drift-lower thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $183.40 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 17, 2026
—
$183.40at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 31, 2026
$173.19–$193.61typical range · internal point $183.00
—
±5.6%
7/10
Low vol defensive drifts sideways near current
1 month
Sep 17, 2026
$168.60–$198.20typical range · internal point $181.50
—
±8.1%
6/10
Mild fade as fallen-angel narrative loses steam
2 months
Oct 17, 2026
$178.50
—
-2.7%
5/10
Value gravity pulls modestly lower absent catalyst
3 months
Nov 17, 2026
$175.00
—
-4.6%
5/10
Post-earnings window reveals no upside surprise
4 months
Dec 17, 2026
$172.00
—
-6.2%
5/10
Year-end rebalancing trims overvalued defensives
5 months
Jan 17, 2027
$170.00
—
-7.3%
4/10
Continued mean reversion toward composite fair value
6 months
Feb 17, 2027
$168.50
—
-8.1%
4/10
Converges near deterministic baseline endpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$168.08
(-8.4%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.